• Losmapimod: A State-Aware p38 MAPK Guide

  2026-08-17

  Losmapimod is an orally active p38 MAPK inhibitor with applications in inflammation, vascular, hypertension, and COPD research. This guide explains how activation-loop conformation and phosphatase access should shape experimental assay design.

• Renal K+ Channels and Perfusion in Septic Rats

  2026-08-17

  This study examined how potassium-channel blockade modifies renal vascular responses to norepinephrine and phenylephrine in rats subjected to cecal ligation and puncture. Its central contribution is the demonstration that channel blockade can have context-dependent effects: it may normalize an ex vivo pressor response while worsening renal blood-flow loss during systemic vasoactive challenge.

• Cyclic di-GMP and Biofilm Persister Control

  2026-08-16

  The 2024 eLife study identifies cyclic di-GMP as a small-molecule antitoxin that restrains the genotoxic toxin HipH during early biofilm development. Its findings connect biofilm-stage signaling with DNA double-strand breaks, genome instability, and antibiotic persistence, offering a mechanistic framework for studying biofilm resilience.

• CKI 7 dihydrochloride: CK1 Workflows

  2026-08-15

  Build reproducible CK1 inhibition experiments with practical guidance for Wnt, circadian, apoptosis, and cancer biology assays. The workflow also shows how CKI 7 dihydrochloride can complement, but not replace, direct testing of the MAPK10–KRT16 metastasis pathway.

• Vincristine sulfate: Assay Reliability Guide

  2026-08-14

  This scenario-based guide explains how Vincristine sulfate, SKU A1765, can support reproducible cell viability, proliferation, and cytotoxicity workflows through mechanism-aware design and careful stock handling. It also provides practical criteria for interpreting concentration-response data and selecting a reliable research reagent.

• Staurosporine Workflows for Apoptosis and Kinase Studies

  2026-08-14

  Staurosporine combines high-potency kinase pathway disruption with a practical apoptosis model for cancer cell lines. This guide translates its broad activity into reproducible workflows for fractional killing, near-death cell-state research, VEGF signaling studies, and assay troubleshooting.

• Cyclic di-GMP in Reliable Viability Assays

  2026-08-13

  This scenario-driven guide explains how Cyclic di-GMP (SKU B7839) can be handled and interpreted in bacterial biofilm, mammalian STING, and cell-viability workflows. It connects recent mechanistic evidence with practical controls for solvent compatibility, assay interference, dosing, and vendor selection.

• ATP Precision in p21 mRNA Bladder Cancer Translation

  2026-08-13

  A translational perspective on how ATP-controlled enzymatic workflows can strengthen the development of localized p21 mRNA-LNP therapy for bladder cancer. The article connects mechanistic validation, assay reproducibility, and strategic product selection without conflating research reagents with clinical efficacy.

• (S)-(+)-Methoprene Workflow for JH Assays

  2026-08-12

  Build more informative juvenile hormone assays with (S)-(+)-Methoprene by aligning dose, developmental stage, and molecular readouts. This practical guide connects metamorphosis studies with vitellogenesis, miRNA–mRNA regulation, receptor signaling, and troubleshooting of solvent, timing, and assay variability.

• Capsaicin-Activated Autophagy in Oxidative-Stressed BMSCs

  2026-08-12

  This study identifies a TRPV1–Ca²⁺–autophagy response through which capsaicin preserves rat bone marrow stromal cell viability and osteogenic function during hydrogen peroxide-induced oxidative stress. Its main contribution is to connect calcium signaling and PI3K/AKT/mTOR-associated autophagy with functional rescue, while also highlighting the limitations of translating an in vitro osteoporosis model into therapeutic practice.

• CTOP: μ-Opioid Receptor Antagonist Workflows

  2026-08-11

  CTOP enables receptor-level validation of opioid effects in cellular assays and pain models, helping separate μ-opioid receptor mechanisms from downstream circuit phenomena. This guide translates recent brain-to-spinal findings into practical preparation, assay design, and troubleshooting decisions.

• Latrunculin B: Reading Actin Perturbation

  2026-08-11

  Latrunculin B is more than an actin polymerization inhibitor: its transient, serum-sensitive behavior can make cytoskeletal experiments more interpretable. This guide connects molecular mechanism, assay timing, and a key antiviral inhibitor study to improve experimental decisions.

• Clozapine as a Mechanistic Benchmark in Schizophrenia

  2026-08-10

  Clozapine offers a powerful pharmacological benchmark for schizophrenia research. This article explains how to pair its receptor, ERK1/2, and hepatotoxicity profiles with circuit-level magnetic stimulation assays without confusing convergent outcomes with shared mechanisms.

• EdU Imaging Kits (Cy5) for HBV-HCC

  2026-08-09

  EdU Imaging Kits (Cy5) provide a morphology-preserving way to quantify S-phase DNA synthesis in HBV-associated hepatocellular carcinoma models. This guide translates the quercetin–EGFR findings into practical fluorescence microscopy and flow cytometry workflows, with controls and troubleshooting for reproducible proliferation data.

• Cyclic di-GMP: Biofilm and STING Research Workflows

  2026-08-08

  Cyclic di-GMP is a versatile intracellular second messenger for dissecting biofilm persistence, genome stability, and STING-driven innate immune signaling. This practical guide connects bacterial adhesion assays with immune modulation research while emphasizing solvent choice, exposure timing, controls, and reproducible troubleshooting.

778 records 9/52 page Previous Next First page 上5页 678910 下5页 Last page